Send Message
Shanghai fine-chemistry CO., Ltd 86-21-17617767348-1 jyzhang@api-chem.com
Fat Burning Femara Anti Estrogen Letrozole Breast Cancer CAS 112809-51-5

Fat Burning Femara Anti Estrogen Letrozole Breast Cancer CAS 112809-51-5

  • High Light

    fat loss steroids

    ,

    weight loss powder

  • ProName
    Letrozole
  • CAS
    112809-51-5
  • MF
    C17H11N5
  • MW
    285.3
  • Appearance
    White Crystalline Powder
  • Purity
    98%
  • Place of Origin
    China
  • Brand Name
    RUN
  • Certification
    ISO9001
  • Model Number
    RUN-AH
  • Minimum Order Quantity
    10g
  • Price
    inquiry
  • Packaging Details
    10g 50g 100g 500g 1kg
  • Delivery Time
    3-7 days
  • Payment Terms
    T/T, , MoneyGram, BTCcoin
  • Supply Ability
    1kg --100kg

Fat Burning Femara Anti Estrogen Letrozole Breast Cancer CAS 112809-51-5

Fat Burning Femara Anti Estrogen Letrozole CAS 112809-51-5 For Breast Cancer High purity 98%

 

Quick Details :

 

Product name:Letrozole
Alias: Femara, Letrozole, TROZET
CAS Registry Number:112809-51-5
Purity: 98%
MF: C17H11N5
MW: 285.3
Character: White crystalline powder.
Delivery: EMS, DHL, TNT, FedEx, UPS
Other drugs in same class:Anastrozole,Letrozole,Tamoxifen citrate,Exemestane
Usage: Letrozole is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body. Side effects from Letrozole include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system.

 

Description:

 

Product name Letrozole
Other name Femara, Letrozole, TROZET
CAS register number 112809-51-5
Molecular formula C17H11N5
Molecular weight 285.3
Molecular structure Fat Burning Raw Steroid Powders Femara Letrozole 98% CAS 112809-51-5 For Breast Cancer
Assay 98%
Appearance White crystalline powder
Package 1kg/aluminium foil bag or as required
Usage can be used as pharmaceutical material
Shipping By express courier
Payment options , MoneyGram, T/T
Price Negotiated

 

Application:

 

Letrozole has been used for ovarian stimulation by fertility doctors since 2001 because it has fewer side-effects than clomiphene (Clomid) and less chance of multiple gestation. A Canadian study presented at the American Society of Reproductive Medicine 2005 Conference suggested that letrozole may increase the risk of birth defects.[citation needed] A more detailed ovulation induction follow-up study found that letrozole, compared with a control group of clomiphene, had significantly lower congenital malformations and chromosomal abnormalities at an overall rate of 2.4% (1.2% major malformations) compared with clomiphene 4.8% (3.0% major malformations). Despite this, India banned the usage of letrozole in 2011, citing potential risks to infants.In 2012, an Indian parliamentary committee said that the drug controller office colluded with letrozole's makers to approve the drug for infertility in India and also stated that letrozole's use for infertility was illegal worldwide; however, such off-label uses are legal in many countries such as the US and UK.
 
The anti-estrogen action of letrozole has been shown to be useful in pretreatment for termination of pregnancy, in combination with misoprostol. It can be used in place of mifepristone, which is expensive and unavailable in many countries.
 
Letrozole is sometimes used as a treatment for gynecomastia, although it is probably most effective at this if caught in an early stage (such as in users of anabolic steroids).
 
Letrozole has also been shown to delay the fusing of the growth plates in mice.When used in combination with growth hormone, letrozole has been shown effective in one adolescent boy with a short stature.

 

Specification

 

COA

 

 

Tests Specifications Results
Appearance White or off-white crystaline powder

White
Crystalline powder

Solubility
 

Soluble in Chloroform;
Soluble in ethanol when heated

Conform
ldentification

(1)Maximum absorption in wavelength of 240 nm
Minimum absorption in wavelength of 215 nm

Conform
Conform

(2)Infrared spectrum should be in accordance the dominant peak of contrast In accordance with the dominant peak of contrast
Melting points 182℃-184℃ 182℃
Related substances ≤0.5% 0.3%
Single impurity ≤0.3% 0.2%
Loss on drying ≤1.0% 0.8%

[Assay]C17H11N5
(On anhydrous basis)

≥98.0% 99.2%
Conclusion Conforms Specifications of Enterprise Standard.